Iktos

The company develops generative AI and robotics solutions to accelerate drug discovery for pharmaceutical and biotech organizations. Its platform includes Makya for molecular design, Spaya for retrosynthesis planning, and an autonomous lab for automated chemical synthesis and testing. These tools are used to identify and optimize drug candidates across therapeutic areas such as oncology, inflammation, and metabolism.